Study Details
Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder: Final Report of the Core Study
Clinicaltrials.gov ID
N/A
Astellas Study ID
178-CL-113
EudraCT ID
N/A
Condition
Overactive Bladder Disease
Phase
N/A
Age
N/A
Sex
Female & Male
Product
mirabegron
Type
Observational
Trial Dates
Jan 2016 - Apr 2019
Masking
Not Available
Enrollment number
185131
Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder: Final Report of the Core Study
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder: Final Report of the Core Study? Contact us by filling our your information to the right and we’ll respond to you.